Literature DB >> 9066980

Growth factor control of growth and epithelial differentiation in embryonic lungs.

H C Nielsen1, A Martin, M V Volpe, D Hatzis, R J Vosatka.   

Abstract

embryonic lung cultures were exposed to either EGF (10 ng/ml) or TGF beta 1 (2 ng/ml) for 72 h, and branching morphogenesis, cell proliferation, and epithelial differentiation (the expression of DSPC synthesis and of surfactant protein C (SP-C) mRNA) were studied. EGF treatment stimulated branching morphogenesis (measured as the number of terminal left lung buds), epithelial differentiation, and cell proliferation. Branching morphogenesis was increased compared to controls after 48 h of culture by 47% and after 72 h by 34% (P < 0.0005). Choline incorporation into DSPC was stimulated by 343% (P = 0.05). SP-C expression was increased sixfold. Thymidine incorporation was stimulated by 49% (P < 0.05). The effects of EGF on thymidine labeling were distributed among epithelial cells of the airway walls and of the branching tips, and also the mesenchyme (P < 0.01 for each area compared to controls). In contrast, TGF beta 1 did not alter the number of terminal left lung buds, inhibited choline incorporation into DSPC by 35% (P < 0.05), and had no effect on thymidine incorporation (87% of control). There was increased thymidine labeling at the branching tips (P < 0.01), while other areas were not different from controls. We conclude that both EGF and TGF beta 1 affect the development of branching morphogenesis and of epithelial differentiation in the embryonic lung.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9066980     DOI: 10.1006/bmme.1996.2560

Source DB:  PubMed          Journal:  Biochem Mol Med        ISSN: 1077-3150


  8 in total

1.  The ErbB4 receptor in fetal rat lung fibroblasts and epithelial type II cells.

Authors:  Washa Liu; Katja Zscheppang; Sandy Murray; Heber C Nielsen; Christiane E L Dammann
Journal:  Biochim Biophys Acta       Date:  2007-05-05

2.  Pigment epithelium-derived factor mediates impaired lung vascular development in neonatal hyperoxia.

Authors:  Anne Chetty; Michelle Bennett; Linh Dang; Daisy Nakamura; Gong-Jie Cao; Sana Mujahid; MaryAnn Volpe; Ira Herman; S Patricia Becerra; Heber C Nielsen
Journal:  Am J Respir Cell Mol Biol       Date:  2015-03       Impact factor: 6.914

3.  Novel 'phage display antibodies identify distinct heparan sulfate domains in developing mammalian lung.

Authors:  S M Thompson; M G Connell; D G Fernig; G B Ten Dam; T H van Kuppevelt; J E Turnbull; E C Jesudason; P D Losty
Journal:  Pediatr Surg Int       Date:  2007-05       Impact factor: 2.003

4.  Sexually dimorphic gene expression that overlaps maturation of type II pneumonocytes in fetal mouse lungs.

Authors:  Marc Simard; Pierre R Provost; Yves Tremblay
Journal:  Reprod Biol Endocrinol       Date:  2006-05-04       Impact factor: 5.211

Review 5.  Interstitial lung disease in children -- genetic background and associated phenotypes.

Authors:  Dominik Hartl; Matthias Griese
Journal:  Respir Res       Date:  2005-04-08

6.  Regulatory interactions between androgens, Hoxb5, and TGF β signaling in murine lung development.

Authors:  MaryAnn V Volpe; Sujatha M Ramadurai; Sana Mujahid; Thanhxuan Vong; Marcia Brandao; Karen T Wang; Lucia D Pham; Heber C Nielsen
Journal:  Biomed Res Int       Date:  2013-09-03       Impact factor: 3.411

7.  Epidermal growth factor receptor (EGFR) pathway genes and interstitial lung disease: an association study.

Authors:  Chong Li; Rongrong Wei; Yava L Jones-Hall; Ragini Vittal; Min Zhang; Wanqing Liu
Journal:  Sci Rep       Date:  2014-05-13       Impact factor: 4.379

8.  Epidermal growth factor receptor inhibition with Gefitinib does not alter lung responses to mechanical ventilation in fetal, preterm lambs.

Authors:  T Brett Kothe; Emily Royse; Matthew W Kemp; Haruo Usuda; Masatoshi Saito; Gabrielle C Musk; Alan H Jobe; Noah H Hillman
Journal:  PLoS One       Date:  2018-07-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.